Recognition of the amyloid precursor protein by human γ-secretase
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
The machinery behind amyloid peptides: β-Amyloid peptides, which are derived from amyloid precursor protein (APP), form the plaques in the brain that are characteristic of Alzheimer's disease. Zhou et al. report a high-resolution structure of a transmembrane segment of APP bound to human γ-secretase, the transmembrane protease that cleaves APP to give β-amyloid peptides (see the Perspective by Lichtenthaler and Güner). Disease-associated mutations within presenilin-1, the catalytic subunit of APP, likely affect how the substrate is bound and thus which peptides are generated, with some being more amyloidogenic. It may now be possible to exploit the features of substrate binding to design inhibitors. Science , this issue p. eaaw0930 ; see also p. 690
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, the 6H8 (61) fragment, obtained through NMR screening from the Maybridge library, may act as a covalent warhead targeting the pathological substrate APP of γ-secretase, thereby hindering Aβ production.569,570”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [570]
In the citing paper
“The alteration of an interaction between APP and PSEN1 has also been demonstrated for other APP mutations within the transmembrane domain close to the γ-secretase processing sites by cryoEM [186], and is associated with increased production of C83/C99 (CTFs) and an increased Aβ42/Aβ40 ratio [187].”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [186]
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
Zheng, S. Q., Palovcak, E., Armache, J.-P., Verba, K. A., Cheng, Y., & Agard, D. A. (2017) · Nature Methods · doi:10.1038/nmeth.4193 · Cited by 7,777
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484 · cited 1×
“Of these, Ab42 and Ab43 are particularly prone to aggregation and formation of amyloid plaques (3, 10, 11).”
BackgroundRELION: Implementation of a Bayesian approach to cryo-EM structure determination
Scheres, S. H. W. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.09.006 · Cited by 5,446
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 1×
“The type I transmembrane (TM) protein APP is first cleaved by a- or b-secretase to generate a transmembrane fragment of 83 or 99 residues (APP-C83 or APPC99), respectively (4, 5) (fig.”
BackgroundThe Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Kopan, R., & Ilagan, M. X. G. (2009) · Cell · doi:10.1016/j.cell.2009.03.045 · Cited by 3,643
Cited by
Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32205-4 · Cited by 5,465
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
“569,570 This could be a supplementary method to avoid potential side effects of γ -secretase inhibitors.”
MethodNotch signaling pathway: architecture, disease, and therapeutics
Zhou, B., Lin, W., Long, Y., Yang, Y., Zhang, H., Wu, K., & Chu, Q. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00934-y · Cited by 1,114
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
γ-Secretase in Alzheimer’s disease
Hur, J.-Y. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00754-8 · Cited by 310
Gaussian accelerated molecular dynamics: Principles and applications
Wang, J., Arantes, P. R., Bhattarai, A., Hsu, R. V., Pawnikar, S., Huang, Y. M., Palermo, G., & Miao, Y. (2021) · WIREs Computational Molecular Science · doi:10.1002/wcms.1521 · Cited by 295
Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies
Sinsky, J., Pichlerova, K., & Hanes, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179207 · Cited by 220
The substrate repertoire of γ-secretase/presenilin
Güner, G., & Lichtenthaler, S. F. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.05.019 · Cited by 195
Structural basis of γ-secretase inhibition and modulation by small molecule drugs
Yang, G., Zhou, R., Guo, X., Yan, C., Lei, J., & Shi, Y. (2021) · Cell · doi:10.1016/j.cell.2020.11.049 · Cited by 189
Self-citationDevelopments, applications, and prospects of cryo‐electron microscopy
Benjin, X., & Ling, L. (2020) · Protein Science · doi:10.1002/pro.3805 · Cited by 166
Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
Zhao, J., Liu, X., Xia, W., Zhang, Y., & Wang, C. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00137 · Cited by 162
Structure and Function of the γ-Secretase Complex
Wolfe, M. S. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00401 · Cited by 116
Genetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene
Bagaria, J., Bagyinszky, E., & An, S. S. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810970 · Cited by 135
Penke, B., Szűcs, M., & Bogár, F. (2020) · Molecules · doi:10.3390/molecules25071659 · Cited by 130
Bottom-up structural proteomics: cryoEM of protein complexes enriched from the cellular milieu
Ho, C.-M., Li, X., Lai, M., Terwilliger, T. C., Beck, J. R., Wohlschlegel, J., Goldberg, D. E., Fitzpatrick, A. W. P., & Zhou, Z. H. (2020) · Nature Methods · doi:10.1038/s41592-019-0637-y · Cited by 115
Peng, Y., Gao, P., Shi, L., Chen, L., Liu, J., & Long, J. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2019.7763 · Cited by 110
Synaptic dysfunction in early phases of Alzheimer's Disease
Pelucchi, S., Gardoni, F., Luca, M. D., & Marcello, E. E. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00022-9 · Cited by 104
Calabrese, G., Molzahn, C., & Mayor, T. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102062 · Cited by 91
Nanoscale FasL Organization on DNA Origami to Decipher Apoptosis Signal Activation in Cells
Berger, R., Weck, J. M., Kempe, S. M., Hill, O., Liedl, T., Rädler, J. O., Monzel, C., & Heuer‐Jungemann, A. (2021) · Small · doi:10.1002/smll.202101678 · Cited by 94
Bai, S. Y., Ren, X., Obata, K., Ito, Y., & Sugioka, K. (2022) · Opto-Electronic Advances · doi:10.29026/oea.2022.210121 · Cited by 88
Bioinspired Artificial Ion Pumps
Mei, T., Zhang, H., & Xiao, K. (2022) · ACS Nano · doi:10.1021/acsnano.2c04550 · Cited by 83
Viles, J. H. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202215785 · Cited by 81
Contribution of the Presenilins in the cell biology, structure and function of γ-secretase
Escamilla‐Ayala, A., Wouters, R., Sannerud, R., & Annaert, W. G. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.02.005 · Cited by 76
Genomics and Functional Genomics of Alzheimer's Disease
Kamboh, M. I. (2022) · Neurotherapeutics · doi:10.1007/s13311-021-01152-0 · Cited by 73
Jasiecki, J., Targońska, M., & Wasąg, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042033 · Cited by 73
Jabir, N. R., Rehman, M. T., Alsolami, K., Shakil, S., Zughaibi, T. A., Alserihi, R. F., Khan, M. S., Alajmi, M. F., & Tabrez, S. S. M. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.2009124 · Cited by 71
Features of MOG required for recognition by patients with MOG antibody-associated disorders
Macrini, C., Gerhards, R., Winklmeier, S., Bergmann, L., Mader, S., Spadaro, M., Vural, A., Smolle, M., Hohlfeld, R., Kümpfel, T., et al. (2021) · Brain · doi:10.1093/brain/awab105 · Cited by 70
Mouchlis, V. D., Melagraki, G., Zacharia, L. C., & Afantitis, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030703 · Cited by 69
Presenilins and γ-Secretase in Membrane Proteostasis
Oikawa, N., & Walter, J. (2019) · Cells · doi:10.3390/cells8030209 · Cited by 68
Biofluid Biomarkers of Alzheimer’s Disease: Progress, Problems, and Perspectives
Huang, S., Wang, Y., & Guo, J. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00836-7 · Cited by 67
Konstantinidis, E., Molisak, A., Perrin, F., Streubel-Gallasch, L., Fayad, S., Kim, D. Y., Petri, K., Aryee, M. J., Aguilar, X., György, B., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.03.022 · Cited by 66
The Brilliance of the Zebrafish Model: Perception on Behavior and Alzheimer’s Disease
Shenoy, A., Banerjee, M., Upadhya, A., Bagwe‐Parab, S., & Kaur, G. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.861155 · Cited by 65
Mechanisms of neurodegeneration — Insights from familial Alzheimer’s disease
Chávez-Gutiérrez, L., & Szaruga, M. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.03.005 · Cited by 58
Secretases in Alzheimer's disease: Novel insights into proteolysis of APP and TREM2
Lichtenthaler, S. F., Tschirner, S. K., & Steiner, H. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.09.003 · Cited by 60
Turning the tide on Alzheimer’s disease: modulation of γ-secretase
Luo, J. E., & Li, Y.-M. (2022) · Cell & Bioscience · doi:10.1186/s13578-021-00738-7 · Cited by 59
Elucidating Tau function and dysfunction in the era of cryo-EM
Lippens, G. M., & Gigant, B. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.008031 · Cited by 57
Unraveling the complexity of γ-secretase
Wolfe, M. S. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.01.005 · Cited by 55
Structure and Dynamics of the Rhomboid Protease GlpG in Liposomes Studied by Solid-State NMR
Shi, C., Öster, C., Bohg, C., Li, L., Lange, S., Chevelkov, V., & Lange, A. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b08952 · Cited by 54
Recent developments of small molecule γ-secretase modulators for Alzheimer's disease
Mekala, S., Nelson, G. L., & Li, Y. (2020) · RSC Medicinal Chemistry · doi:10.1039/d0md00196a · Cited by 54
Petit, D., Hitzenberger, M., Lismont, S., Zoltowska, K. M., Ryan, N. S., Mercken, M. H., Bischoff, F., Zacharias, M., & Chávez‐Gutiérrez, L. (2019) · The EMBO Journal · doi:10.15252/embj.2019101494 · Cited by 53
Substrate recognition and processing by γ-secretase
Wolfe, M. S. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.07.004 · Cited by 53
Liu, L., Lauro, B. M., He, A., Lee, H., Bhattarai, S., Wolfe, M. S., Bennett, D. A., Karch, C. M. M., Young‐Pearse, T. L., Dominantly Inherited Alzheimer Network (DIAN), et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12646 · Cited by 52
Molecular mechanism of substrate recognition and cleavage by human γ-secretase
Guo, X., Li, H., Yan, C., Lei, J., Zhou, R., & Shi, Y. (2024) · Science · doi:10.1126/science.adn5820 · Cited by 50
Self-citationPARL Protease: A Glimpse at Intramembrane Proteolysis in the Inner Mitochondrial Membrane
Lysyk, L., Brassard, R., Touret, N., & Lemieux, M. J. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.04.006 · Cited by 49
Mechanisms of γ-Secretase Activation and Substrate Processing
Bhattarai, A., Devkota, S., Bhattarai, S., Wolfe, M. S., & Miao, Y. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00296 · Cited by 49
Bon, C. L., Michon, B., Popot, J., & Zoonens, M. A. (2021) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583521000044 · Cited by 49
Successive cleavage of β-amyloid precursor protein by γ-secretase
Funamoto, S., Tagami, S., Okochi, M., & Morishima‐Kawashima, M. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.04.002 · Cited by 48
Roles of physical exercise in neurodegeneration: reversal of epigenetic clock
Xu, M., Zhu, J., Liu, X.-D., Luo, M.-Y., & Xu, N.-J. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00254-1 · Cited by 46
Physiological functions of SPP/SPPL intramembrane proteases
Mentrup, T., Cabrera-Cabrera, F., Fluhrer, R., & Schröder, B. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03470-6 · Cited by 46
Reactions at Biomembrane Interfaces
Bondar, A., & Lemieux, M. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00596 · Cited by 45
Modulating Hinge Flexibility in the APP Transmembrane Domain Alters γ-Secretase Cleavage
Götz, A., Mylonas, N. T., Högel, P., Silber, M., Heinel, H., Menig, S., Vogel, A., Feyrer, H., Huster, D., Luy, B., et al. (2019) · Biophysical Journal · doi:10.1016/j.bpj.2019.04.030 · Cited by 45
Glaeser, R. M. (2021) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072020-020231 · Cited by 45
Cholesterol and Lipid Rafts in the Biogenesis of Amyloid-β Protein and Alzheimer's Disease
Pantelopulos, G. A., Abraham, C. B., & Straub, J. E. (2024) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-062823-023436 · Cited by 43
The vexing complexity of the amyloidogenic pathway
Castro, M., Hadziselimovic, A., & Sanders, C. R. (2019) · Protein Science · doi:10.1002/pro.3606 · Cited by 43
Liu, L., Lauro, B. M., Wolfe, M. S., & Selkoe, D. J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100393 · Cited by 40
Secretome Analysis: Reading Cellular Sign Language to Understand Intercellular Communication
Wu, W., & Krijgsveld, J. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100692 · Cited by 42
Cryo-temperature effects on membrane protein structure and dynamics
Mehra, R., Dehury, B., & Kepp, K. P. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp06723j · Cited by 41
Hurley, E. M., Mozolewski, P., Dobrowolski, R., & Hsieh, J. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.05.018 · Cited by 41
Dehury, B., Tang, N., & Kepp, K. P. (2019) · Biochemical Journal · doi:10.1042/bcj20190023 · Cited by 40
Sun, Y., Islam, S., Michikawa, M., & Zou, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031757 · Cited by 40
Familial Alzheimer mutations stabilize synaptotoxic γ-secretase-substrate complexes
Devkota, S., Zhou, R., Nagarajan, V., Maesako, M., Do, H. N., Noorani, A. A., Overmeyer, C., Bhattarai, S., Douglas, J. T., Saraf, A., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113761 · Cited by 40
Self-citationNie, P., Vartak, A., & Li, Y. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.03.002 · Cited by 38
De Strooper, B., & Karran, E. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00057-w · Cited by 36
Gadhave, K., Gehi, B. R., Kumar, P., Xue, B., Uversky, V. N., & Giri, R. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03414-9 · Cited by 36
Alzheimer's disease – Where do we go from here?
Борисович, Б. И. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.08.075 · Cited by 36
The dynamics of γ-secretase and its substrates
Hitzenberger, M., Götz, A., Menig, S., Brunschweiger, B., Zacharias, M., & Scharnagl, C. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.04.008 · Cited by 35
Urban, A. S., Pavlov, K. V., Kamynina, A. V., Okhrimenko, I. S., Arseniev, A. S., & Bocharov, E. V. (2021) · Molecules · doi:10.3390/molecules26102897 · Cited by 34
Zhao, J., Tan, X., He, Y., Yuan, R., Wang, S., & Chen, S. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c05270 · Cited by 34
Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease
Александровна, П. Е., Chernyuk, D., & Борисович, Б. И. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200528162046 · Cited by 34
Dehury, B., Tang, N., Mehra, R., Blundell, T. L., & Kepp, K. P. (2020) · RSC Advances · doi:10.1039/d0ra04683c · Cited by 34
Steiner, A., Schlepckow, K., Brunner, B., Steiner, H., Haass, C., & Hagn, F. (2020) · The EMBO Journal · doi:10.15252/embj.2019104247 · Cited by 33
Mechanism of Tripeptide Trimming of Amyloid β-Peptide 49 by γ-Secretase
Bhattarai, A., Devkota, S., Do, H. N., Wang, J., Bhattarai, S., Wolfe, M. S., & Miao, Y. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.1c10533 · Cited by 33
Structure and mechanism of the γ-secretase intramembrane protease complex
Wolfe, M. S., & Miao, Y. (2022) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2022.102373 · Cited by 32
Trambauer, J., Sarmiento, R. M. R., Fukumori, A., Feederle, R., Baumann, K., & Steiner, H. (2019) · EMBO Reports · doi:10.15252/embr.201947996 · Cited by 32
A manifesto for Alzheimer’s disease drug discovery in the era of disease-modifying therapies
Hering, H., Bussière, T., Liu, C., Glajch, K. E., Weihofen, A., Grogan, J. L., & Walsh, D. M. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00872-7 · Cited by 31
Trambauer, J., Fukumori, A., & Steiner, H. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.01.011 · Cited by 31
Hou, J., Bi, H., Ye, Z., Huang, W., Zou, G., Zou, X., Shi, Y. S., Shen, Y., Ma, Q., Kirchhoff, F., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2455-19.2021 · Cited by 31
Self-citationStructure and dynamics of γ-secretase with presenilin 2 compared to presenilin 1
Dehury, B., Tang, N., Blundell, T. L., & Kepp, K. P. (2019) · RSC Advances · doi:10.1039/c9ra02623a · Cited by 30
Zhang, Y., Yang, G., Zhao, J., He, Y., Yuan, R., & Chen, S. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c00831 · Cited by 30
Self-citationDo, H. N., Devkota, S., Bhattarai, A., Wolfe, M. S., & Miao, Y. (2023) · Communications Biology · doi:10.1038/s42003-023-04539-1 · Cited by 30
Escamilla-Ayala, A. A., Sannerud, R., Mondin, M., Poersch, K., Vermeire, W., Paparelli, L., Berlage, C., Koenig, M., Chavez-Gutierrez, L., Ulbrich, M. H., et al. (2020) · eLife · doi:10.7554/elife.56679 · Cited by 29
Neuroinflammation and Alzheimer's disease: Unravelling the molecular mechanisms
Kakkar, A., Singh, H., Singh, B. K., Kumar, A., Mishra, A. K., & Chopra, H. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251374353 · Cited by 29
Spastic paraplegia preceding PSEN1 ‐related familial Alzheimer's disease
Chelban, V., Breza, M., Szaruga, M., Vandrovcová, J., Murphy, D. P., Lee, C., Alikhwan, S., Bourinaris, T., Vavougios, G. D., Ilyas, M., et al. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12186 · Cited by 29
Molecular basis for isoform-selective inhibition of presenilin-1 by MRK-560
Guo, X., Wang, Y., Zhou, J., Jin, C., Wang, J., Jia, B., Jing, D., Yan, C., Lei, J., Zhou, R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33817-5 · Cited by 29
Self-citationProbing Mechanisms and Therapeutic Potential of γ-Secretase in Alzheimer’s Disease
Wolfe, M. S. (2021) · Molecules · doi:10.3390/molecules26020388 · Cited by 28
Signaling Functions of Intramembrane Aspartyl-Proteases
Papadopoulou, A. A., & Fluhrer, R. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.591787 · Cited by 27
Insights into membrane-bound presenilin 2 from all-atom molecular dynamics simulations
Dehury, B., Tang, N., & Kepp, K. P. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1655481 · Cited by 27
Wang, J., Fourriere, L., & Gleeson, P. A. (2024) · Biochemical Journal · doi:10.1042/bcj20240056 · Cited by 27
Mechanistic insights into intramembrane proteolysis by E. coli site-2 protease homolog RseP
Imaizumi, Y., Takanuki, K., Miyake, T., Takemoto, M., Hirata, K., Hirose, M., Oi, R., Kobayashi, T., Miyoshi, K., Aruga, R., et al. (2022) · Science Advances · doi:10.1126/sciadv.abp9011 · Cited by 26
Discovery of Cellular Roles of Intramembrane Proteases
Beard, H. A., Barniol‐Xicota, M., Yang, J., & Verhelst, S. H. L. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00404 · Cited by 26
Zhou, R., Yang, G., & Shi, Y. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.09.004 · Cited by 26
Self-citationWang, X., Zhou, R., Sun, X., Li, J., Wang, J., Yue, W., Wang, L., Liu, H., Shi, Y., & Zhang, D. (2023) · Advanced Science · doi:10.1002/advs.202303411 · Cited by 25
Self-citationCurtis, D., Bakaya, K., Sharma, L., & Bandyopadhyay, S. (2020) · Annals of Human Genetics · doi:10.1111/ahg.12375 · Cited by 25
Zhang, Y., Zhao, J., Yang, G., He, Y., Chen, S., & Yuan, R. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c07598 · Cited by 25
Self-citationSpitz, C., Schlosser, C., Guschtschin-Schmidt, N., Stelzer, W., Menig, S., Götz, A., Haug-Kröper, M., Scharnagl, C., Langosch, D., Muhle-Goll, C., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101775 · Cited by 23
Distinguishing the Effect on the Rate and Yield of Aβ42 Aggregation by Green Tea Polyphenol EGCG
Park, G., Xue, C., Wang, H., & Guo, Z. (2020) · ACS Omega · doi:10.1021/acsomega.0c02063 · Cited by 23
γ-Secretase Modulatory Proteins: The Guiding Hand Behind the Running Scissors
Wong, E., Frost, G. R., & Li, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.614690 · Cited by 23
Structural determinants of cholesterol recognition in helical integral membrane proteins
Marlow, B., Kuenze, G., Li, B., Sanders, C. R., & Meiler, J. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.02.028 · Cited by 23
Uncovering the Binding Mode of γ -Secretase Inhibitors
Hitzenberger, M., & Zacharias, M. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00272 · Cited by 22
Metadata
- Authors
- Zhou, R., Yang, G., Guo, X., Zhou, Q., Lei, J., & Shi, Y.
- Affiliations
- Center for Life Sciences (CN)
- Westlake University (CN)
- Corresponding author
- Zhou, Rui
- Yang, Guanghui
- Shi, Yigong
- Venue
- Science
- Published
- 2019-02-15
- Volume
- 363
- Issue
- 6428
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4231640017
- Cited by
- 304
- References
- 55
- Citations by year
- 2026: 22 · 2025: 26 · 2024: 39 · 2023: 38 · 2022: 45 · 2021: 48 · 2020: 52 · 2019: 34
- FWCI
- 31.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- Funders
- National Natural Science Foundation of China (31621092)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid precursor protein, gamma-secretase, beta-amyloid peptide, Alzheimer's disease, presenilin 1, substrate recognition, protein complex structure, disease-associated mutations, substrate binding, gamma-secretase inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.